Evaluating potential program cost savings with a single-dose HPV vaccination schedule: a modeling study.

ABSTRACT:

Background

There is limited evidence on the magnitude of the potential program cost savings associated with the World Health Organization-endorsed single-dose schedule for the human papillomavirus (HPV) vaccine. The objective of this analysis was to model the delivery and vaccine procurement cost implications of the new schedule.

Methods

The analysis leveraged primary data during a study evaluating the HPV vaccine delivery costs and operational context in 5 countries (Ethiopia, Guyana, Rwanda, Sri Lanka, and Uganda) implementing a two-dose schedule. To estimate the cost for the single-dose schedule, we adjusted the two-dose schedule cost estimates to account for differences in the frequency of activities, whether activities differed by HPV vaccine dose or session, and differ

SUBMITTER: Slavkovsky R 

PROVIDER: S-EPMC11555269 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature